ICICI Prudential Nifty Pharma Index Fund-Growth
Equity
Sectoral-Pharma
₹-0.75% 1D
NAV on
Overview
Chart
Returns
Asset Allocation
Fund Info
Risk & Return Ratio
Fund Overview
- Rating
2 - Minimum Investment₹1000
- NAV (Net Asset Value)₹N/A
- AUM (Fund size)₹157 Cr
- Created on3 Dec 2022
Fund Ranking
#10
/ 17 in Sectoral-Pharma
Risk Level
Very High
Very High
Loading...
Returns
Trailing Return
Rolling Return
- 6 Month19.5%
- 1 Year19.3%
- 3 Year (CAGR)19.5%
- All Time (CAGR)19.5%
Category Return
- 6 Month18.4%
- 1 Year13.5%
- 3 Year (CAGR)20.1%
- All Time (CAGR)16.9%
Asset Allocation
- Equity99.9%
- Other0.1%
Top 5 Holdings
Top 5 Sectors
- Aurobindo Pharma4.69%
- Cipla7.83%
- Dr. Reddy's Laboratories6.95%
- Ipca Laboratories2.71%
- Abbott India1.31%
Fund Information
- Expense Ratio1.18%
- Exit LoadNo Exit Load
- Lock-In PeriodNo Lock-In
Managed By
Kewal Shah
Feb 2024 - Present
Priya Sridhar
Feb 2024 - Present
Kayzad Eghlim
Nov 2022 - Present
Nishit Patel
Nov 2022 - Present
Ashwini Jemin Bharucha
Dec 2024 - Present
Venus Ahuja
Nov 2025 - Present
Risk & Return Ratio
- Sharpe Ratio
Sharpe Ratio evaluates a fund's return relative to its risk. Higher values signify better risk-adjusted performance. 0.81 - Standard Deviation
Standard deviation measures the volatility of a fund's returns. The higher the value, the riskier the investment. 16.15 - Alpha
Alpha in mutual funds measures excess return relative to a benchmark, indicating a manager's skill at generating returns beyond market performance. -1.05 - Beta
Beta in mutual funds indicates a fund's sensitivity to market changes. A beta over 1 means it's more volatile than the market, while below 1 implies less volatility. 0.94